David Georges
Director of Finance/CFO at CELYAD ONCOLOGY SA
Profile
David Georges is currently the Vice President-Finance & Administration at Celyad Oncology SA. Previously, he worked as the Director-Finance & Administration at DIAsource ImmunoAssays SA and as a Financial Manager at Merck KGaA.
Mr. Georges completed his undergraduate degree at Université Catholique de Louvain.
David Georges active positions
Companies | Position | Start |
---|---|---|
CELYAD ONCOLOGY SA | Director of Finance/CFO | 31/12/2018 |
Former positions of David Georges
Companies | Position | End |
---|---|---|
MERCK KGAA | Corporate Officer/Principal | - |
DIAsource ImmunoAssays SA
DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Director of Finance/CFO | - |
Training of David Georges
Université Catholique de Louvain | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MERCK KGAA | Health Technology |
CELYAD ONCOLOGY SA | Health Technology |
Private companies | 1 |
---|---|
DIAsource ImmunoAssays SA
DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
- Stock Market
- Insiders
- David Georges